We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

PII Expands Drug Formulation and Manufacturing Capabilities With Hot Melt Extrusion Technology

News   Aug 01, 2011

 
PII Expands Drug Formulation and Manufacturing Capabilities With Hot Melt Extrusion Technology
 
 
Advertisement
 

RELATED ARTICLES

RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19

News

A clinical trial of RLF-100 (aviptadil) has shown rapid recovery from respiratory failure in critically ill patients with COVID-19.

READ MORE

Expert Panel Makes Weak Recommendation for Use of Remdesivir To Treat Severe COVID-19

News

International experts have made a weak recommendation for the use of remdesivir in patients with severe COVID-19, advising continuation of patient enrolment for ongoing clinical trials of remdesivir to enable the collection of additional data.

READ MORE

Positive Results Reported for Phase 2 Study of Lyme Disease Vaccine Candidate

News

Positive initial results have been reported for the Phase 2 study of Lyme disease vaccine candidate VLA15.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE